Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Will mTOR inhibitors make it as cancer drugs?

× No keyword cloud information.

71 in total

1. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells.

Authors: Yewseok Suh; Farrukh Afaq; Naghma Khan; Jeremy J Johnson; Fatima H Khusro; Hasan Mukhtar
Journal: Carcinogenesis Date: 2010-06-08 Impact factor: 4.944

2. High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.

Authors: Paige Yellen; Mahesh Saqcena; Darin Salloum; Jiangnan Feng; Angela Preda; Limei Xu; Vanessa Rodrik-Outmezguine; David A Foster
Journal: Cell Cycle Date: 2011-11-15 Impact factor: 4.534

Review 3. New molecular targets for treatment of lymphoma.

Authors: Barbara Pro; Anas Younes
Journal: Curr Oncol Rep Date: 2004-09 Impact factor: 5.075

Review 4. The potential role of mTOR inhibitors in the treatment of endocrine tumors.

Authors: S Grozinsky-Glasberg; I Shimon
Journal: J Endocrinol Invest Date: 2010-05-05 Impact factor: 4.256

5. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study.

Authors: Susan E Krown; Debasmita Roy; Jeannette Y Lee; Bruce J Dezube; Erin G Reid; Raman Venkataramanan; Kelong Han; Ethel Cesarman; Dirk P Dittmer
Journal: J Acquir Immune Defic Syndr Date: 2012-04-15 Impact factor: 3.731

Review 6. Signaling by target of rapamycin proteins in cell growth control.

Authors: Ken Inoki; Hongjiao Ouyang; Yong Li; Kun-Liang Guan
Journal: Microbiol Mol Biol Rev Date: 2005-03 Impact factor: 11.056

7. IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.

Authors: Michal Marzec; Xiaobin Liu; Monika Kasprzycka; Agnieszka Witkiewicz; Puthiyaveettil N Raghunath; Mouna El-Salem; Erle Robertson; Niels Odum; Mariusz A Wasik
Journal: Blood Date: 2007-11-19 Impact factor: 22.113

8. Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia.

Authors: Steven M Chan; Andrew P Weng; Robert Tibshirani; Jon C Aster; Paul J Utz
Journal: Blood Date: 2007-03-15 Impact factor: 22.113

9. The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells.

Authors: Olivier Dormond; Joren C Madsen; David M Briscoe
Journal: J Biol Chem Date: 2007-06-06 Impact factor: 5.157

10. Intravesical delivery of rapamycin suppresses tumorigenesis in a mouse model of progressive bladder cancer.

Authors: Catherine M Seager; Anna M Puzio-Kuter; Trushar Patel; Shalini Jain; Carlos Cordon-Cardo; James Mc Kiernan; Cory Abate-Shen
Journal: Cancer Prev Res (Phila) Date: 2009-12-01